Riente, L. 2004. The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis. Reumatismo. 56, s1 (Mar. 2004), 74–79. DOI:https://doi.org/10.4081/reumatismo.2004.1s.74.